Back
Results - Announcements
Natural Capsules Ltd consolidated sales down 16.66% on year in Q2FY2026, net profit improved by 15.26%
12-Aug-2026, 08:06
Natural Capsules Ltd share price slipped 1.37% to Rs 166.15 after the company's net profit rose by 15.26% to Rs 5.74 crore, while revenue from operations declined 16.66% to Rs 48.71 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.12 lakh crore, rising 4.31%. It has marginally improved by 0.98% over last one week and advanced by 11.49% in last one month while the market capitalization of Natural Capsules Ltd has inched up 8.62% and 4.55% in the same period respectively. Profit before tax (PBT) of Natural Capsules Ltd stood at Rs 5.83 crore in Q2 FY26, declining 3.80% year-on-year, and advancing by 14.76% quarter-on-quarter. EBITDA came in at Rs 1 crore, rallying 2975.00% YoY and tanking 315.79% sequentially. Total expenses contracted by 15.44% to Rs 51.92 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 28.92 crore, slightly declining by 1.87% YoY, while employee benefits expense was at Rs 5.24 crore, softening 4.38% YoY. For the TTM ended FY26, revenue from operations rose 10.63% to Rs 187.2 crore, while net profit tumbled by 4077.42% to Rs 24.66 crore, compared to previous TTM. EBITDA soared by 2384% to Rs 3.29 crore, and PBT collapsed by 1100.72% to Rs 27.92 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 10.92 crore in FY26, as against Rs 26.75 crore in FY25. Natural Capsules Ltd crashed 22.05% in last one year, underperforming the benchmark BSE Sensex which has eased by 3.04% during the same period.
Natural Capsules Ltd share price slipped 1.37% to Rs 166.15 after the company's net profit rose by 15.26% to Rs 5.74 crore, while revenue from operations declined 16.66% to Rs 48.71 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.12 lakh crore, rising 4.31%. It has marginally improved by 0.98% over last one week and advanced by 11.49% in last one month while the market capitalization of Natural Capsules Ltd has inched up 8.62% and 4.55% in the same period respectively. Profit before tax (PBT) of Natural Capsules Ltd stood at Rs 5.83 crore in Q2 FY26, declining 3.80% year-on-year, and advancing by 14.76% quarter-on-quarter. EBITDA came in at Rs 1 crore, rallying 2975.00% YoY and tanking 315.79% sequentially. Total expenses contracted by 15.44% to Rs 51.92 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 28.92 crore, slightly declining by 1.87% YoY, while employee benefits expense was at Rs 5.24 crore, softening 4.38% YoY. For the TTM ended FY26, revenue from operations rose 10.63% to Rs 187.2 crore, while net profit tumbled by 4077.42% to Rs 24.66 crore, compared to previous TTM. EBITDA soared by 2384% to Rs 3.29 crore, and PBT collapsed by 1100.72% to Rs 27.92 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 10.92 crore in FY26, as against Rs 26.75 crore in FY25. Natural Capsules Ltd crashed 22.05% in last one year, underperforming the benchmark BSE Sensex which has eased by 3.04% during the same period.
